Cargando…

Changes and influencing factors of liver volume after transjugular intrahepatic portosystemic shunt: a retrospective cohort study

BACKGROUND: Liver volume is an important measure of liver reserve and helps to determine the course of liver disease. This study aimed to observe the dynamic changes of liver volume after transjugular intrahepatic portosystemic shunt (TIPS) and analyze the related factors. METHODS: Clinical data of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bai, Yaowei, Liu, Jiacheng, Zhao, Jianbo, Ma, Jinqiang, Wang, Yingliang, Wang, Chaoyang, Ju, Shuguang, Zhou, Chen, Yang, Chongtu, Huang, Songjiang, Li, Tongqiang, Chen, Yang, Yao, Wei, Xiong, Bin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10167424/ https://www.ncbi.nlm.nih.gov/pubmed/37179928 http://dx.doi.org/10.21037/qims-22-482

Ejemplares similares

The impact of thrombocytopenia on variceal bleeding in cirrhotic patients with transjugular intrahepatic portosystemic shunt
por: Chen, Yang, et al.
Publicado: (2023)

Effect of splenectomy on the outcomes in patients with cirrhosis receiving transjugular intrahepatic portosystemic shunt
por: Yang, Chongtu, et al.
Publicado: (2021)

Dynamic changes in liver function after transjugular intrahepatic portosystemic shunt in patients with cirrhosis
por: Wang, Chaoyang, et al.
Publicado: (2022)

Potential Benefits of Underdilation of 8-mm Covered Stent in Transjugular Intrahepatic Portosystemic Shunt Creation
por: Liu, Jiacheng, et al.
Publicado: (2021)

Mild Prolongation of Prothrombin Time Does Not Affect the Safety and Prognosis of Transjugular Intrahepatic Portal Shunt: Based on Real-World Data
por: Bai, Yaowei, et al.
Publicado: (2023)

The combination of balloon-assisted antegrade transvenous obliteration and transjugular intrahepatic portosystemic shunt for the management of cardiofundal varices hemorrhage
por: Liu, Jiacheng, et al.
Publicado: (2020)

A new choice of stent for transjugular intrahepatic portosystemic shunt creation: Viabahn ePTFE covered stent/bare metal stent combination
por: Liu, Jiacheng, et al.
Publicado: (2020)

The Evolution of Transjugular Intrahepatic Portosystemic Shunt: Tips
por: Fanelli, Fabrizio
Publicado: (2014)

Parallel Shunt for the Treatment of Transjugular Intrahepatic Portosystemic Shunt Dysfunction
por: Luo, Xuefeng, et al.
Publicado: (2013)

Transjugular Intrahepatic Portosystemic Shunt Placement in Patients with Schistosomiasis-Induced Liver Fibrosis
por: Liu, Jiacheng, et al.
Publicado: (2019)

Apatinib Plus Camrelizumab With/Without Chemoembolization for Hepatocellular Carcinoma: A Real-World Experience of a Single Center
por: Ju, Shuguang, et al.
Publicado: (2022)

Donafenib-Loaded Callispheres Beads Embolization in a VX2 Liver Tumor: Investigating Efficacy, Safety, and Improvement of Tumor Angiogenesis After Embolization
por: Li, Tongqiang, et al.
Publicado: (2021)

Portal flow diversion based on portography is superior than puncture site in the prediction of overt hepatic encephalopathy after TIPS creation
por: Yang, Chongtu, et al.
Publicado: (2022)

Transjugular intrahepatic portosystemic shunt in patients with cirrhosis: Indications and posttransjugular intrahepatic portosystemic shunt complications in 2020
por: Horhat, Adelina, et al.
Publicado: (2021)

Transjugular intrahepatic portosystemic shunt assisted with trans-splenic access
por: Cheng, Zhang, et al.
Publicado: (2019)

Late combination of transarterial chemoembolization with apatinib and camrelizumab for unresectable hepatocellular carcinoma is superior to early combination
por: Ju, Shuguang, et al.
Publicado: (2022)

Management of traumatic peripheral artery pseudoaneurysm: A 10-year experience at a single center
por: Wang, Yingliang, et al.
Publicado: (2022)

Transjugular Intrahepatic Portosystemic Shunt Versus Surgical Shunting in the Management of Portal Hypertension
por: Huang, Long, et al.
Publicado: (2015)

The Pull-Through Technique for Recanalization of Transjugular Intrahepatic Portosystemic Shunt Dysfunction
por: Chen, Si-liang, et al.
Publicado: (2020)

A VEGFR targeting peptide-drug conjugate (PDC) suppresses tumor angiogenesis in a TACE model for hepatocellular carcinoma therapy
por: Wang, Dongyuan, et al.
Publicado: (2022)

Using transjugular intrahepatic portosystemic shunt as the first‐line therapy in secondary prophylaxis of variceal hemorrhage
por: Liu, Jiacheng, et al.
Publicado: (2019)

Transcaval Transjugular Intrahepatic Portosystemic Shunt: Preliminary Clinical Results
por: Lee, Kwang-Hun, et al.
Publicado: (2003)

Quality Improvement Guidelines for Transjugular Intrahepatic Portosystemic Shunt (TIPS)
por: Krajina, Antonin, et al.
Publicado: (2012)

Transjugular intrahepatic portosystemic shunt in cirrhosis: An exhaustive critical update
por: Rajesh, Sasidharan, et al.
Publicado: (2020)

Transjugular intrahepatic portosystemic stent-shunt in the management of portal hypertension
por: Tripathi, Dhiraj, et al.
Publicado: (2020)

Transjugular Intrahepatic Portosystemic Shunt for Refractory Ascites in Gaucher Disease
por: Adhyaru, Kunal, et al.
Publicado: (2022)

Racial disparities in transjugular intrahepatic portosystemic shunt procedure outcomes
por: Helzberg, James H, et al.
Publicado: (2022)

Biliary Obstruction After Transjugular Intrahepatic Portosystemic Shunt Placement
por: Patel, Feenalie, et al.
Publicado: (2021)

Modified gun-sight transjugular intrahepatic portosystemic shunt technique
por: Lukies, Matthew, et al.
Publicado: (2022)

Evolution, progress, and prospects of research on transjugular intrahepatic portosystemic shunt applications
por: Wang, Peng, et al.
Publicado: (2021)

Clinical efficacy of transjugular intrahepatic portosystemic shunt in the treatment of hepatopulmonary syndrome
por: Zhao, Hongwei, et al.
Publicado: (2017)

Inclusion of sarcopenia improves the prognostic value of MELD score in patients after transjugular intrahepatic portosystemic shunt
por: Bai, Yao-wei, et al.
Publicado: (2022)

Pathological Predictors of Shunt Stenosis and Hepatic Encephalopathy after Transjugular Intrahepatic Portosystemic Shunt
por: He, Fuliang, et al.
Publicado: (2016)

Liver fibrosis promotes immunity escape but limits the size of liver tumor in a rat orthotopic transplantation model
por: Li, Tongqiang, et al.
Publicado: (2021)

Transient Hemolytic Anemia after Transjugular Intrahepatic Portosystemic Stent Shunt
por: Garcia-Rebollo, Sagrario, et al.
Publicado: (1996)

The Transjugular Intrahepatic Portosystemic Shunt in the Treatment of Portal Hypertension: Current Status
por: Pomier-Layrargues, Gilles, et al.
Publicado: (2012)

The effects of a transjugular intrahepatic portosystemic shunt on the diagnosis of hepatocellular cancer
por: Wong, Katherine, et al.
Publicado: (2018)

Precision Onion Skinning Technique for Transjugular Intrahepatic Portosystemic Shunt Revision
por: Matteo, Jerry, et al.
Publicado: (2018)

Effect of initial stent position on patency of transjugular intrahepatic portosystemic shunt
por: Luo, Shi-Hua, et al.
Publicado: (2017)

Stress-Induced Takotsubo Cardiomyopathy After Transjugular Intrahepatic Portosystemic Shunt
por: Lamb, Bernadette, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_qa0uhf14aiqhl4snd52cg6gune